≡ Aptivus(R) (tipranavir) Capsules Granted Full Approval By The U.S. FDA Part 2
— Use notify when prescribe APTIVUS/r surrounded by patients who may be at stake in favour of increased bleeding or who be acknowledgment medication set to mortgage the risk of bleeding.
— The risk-benefit of APTIVUS/r have not be verified in pediatric patients.
There are no organization grades demonstrating the effect […]
